Physician profile
James E Crockett
NPI 1891955639
$2,998.47
in general payments reported to CMS, 2019-2025
18 companies · $725 in 2025
The $725 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $276 · 2021: $178 · 2022: $617 · 2023: $668 · 2024: $359 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,751.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $453.25 | 2019-2025 | Cequa |
| Alcon Vision LLC | $407.09 | 2019-2025 | Precision7 |
| Johnson & Johnson Vision Care, INC. | $406.83 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $248.08 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $236.86 | 2024-2025 | Tecnis Simplicity, Amo Phaco Needle |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $217.59 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $216.98 | 2022-2025 | Infuse, Miebo, Xiidra |
| Carl Zeiss Meditec USA, INC. | $130.06 | 2025 | Iolmaster 700 |
| Coopervision INC. | $124.99 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens |
| Novartis Pharmaceuticals Corporation | $122.44 | 2019-2023 | |
| Oyster Point Pharma, INC. | $87.95 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $74.74 | 2022-2025 | |
| Allergan, INC. | $71.47 | 2020-2022 | |
| Dompe US, INC. | $71.03 | 2022-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $45.55 | 2025 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $35.97 | 2025 | Vevye |
| Shire North American Group INC | $33.96 | 2019 | |
| Alcon Research LLC | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Crockett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.